Novartis unit opens $200m manufacturing plant in Tuas
Published on Apr 14, 2014 1:29 PM
A $200 million manufacturing facility built by a subsidiary of Swiss pharmaceutical giant Novartis officially opened at Tuas Biomedical Park II on Monday.
The 3 ha facility produces vision-saving medical products under Alcon, Novartis' eyecare arm.
Five top-selling ophthalmic drugs that treat eye maladies including conjunctivitis and glaucoma are made at the facility, including eye drop Systane and allergy solution Patanol8.
Production at the plant started in July 2013, with more than 25 million units distributed yearly to countries across Asia and Europe.
To continue reading, log in if you are a subscriber
If you are not a subscriber, you can get instant, unlimited access here